Advertisement

Search Results for "Lifescan To Exit Hospital Market"

18:58 EDT 25th May 2013 | BioPortfolio

Original Source: LifeScan, Inc.

For more than two decades, LifeScan has been committed to improving the quality of life for people with diabetes. LifeScan pioneered the modern era of blood glucose monitoring with the introduction of OneTouch® technology. By eliminating wiping and timing procedures, OneTouch Systems helped bring blood glucose testing out of the laboratory and into the hands of patients. Five years after incorporation, LifeScan joined the Johnson & Johnson family of companies in November 1986. Headquartered in Milpitas, Ca...

Matching Channels

Sinus Node Dysfunction

Sinus node dysfunction refers to a number of conditions producing physiologically inappropriate atrial rates. Symptoms may be minimal or include weakness, palpitations, and syncope. Diagnosis is by...

Pseudomonas aeruginosa Vaccines

Pseudomonas aeruginosa is an opportunistic gram-negative bacteria that lives in soil, water, and even in environments like hot tubs. For most healthy people, this bacteria seldom poses a problem. Pse...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

What is Healthcare?

Healthcare (health-care) is broadly defined as any care, service, or supply related to the physical or mental health and well-being of an individual through the services offered by the medical and a...

Self-Management

Self-management is quite a new idea in healthcare, and it is for patient with long-term conditions to regain some control over their life, and to be able lead a better life,  despite their heal...

Matching News

[LifeScan] acquires [Calibra Medical]

[LifeScan Inc.] (a division of [Johnson & Johnson] focused on devices for diabetics) has acquired [Calibra Medical Inc.], a privately held company that has developed a wearable insulin patch. Formed...

CCS Medical Announces Agreement with LifeScan

FARMERS BRANCH, Texas, March 6, 2013 /PRNewswire/ -- CCS Medical announced today that is has entered into an agreement with LifeScan, Inc., to provide diabetes testing supplies to patients across...

RQx Antibiotic Collaboration With Genentech Marks Third Exit For Avalon Ventures This Year

Avalon-backed RQx will team with Genentech to discover and develop antibiotics against a novel, undisclosed target. The deal essentially is an exit for hybrid VC firm Avalon, which already has exit de...

UPDATE 2-Avon plans to cut over 400 jobs, exit Ireland

April 8 (Reuters) - Avon Products Inc said on Monday it will slash more than 400 jobs and exit the Irish market, the latest moves in the new chief executive's plan to return the beauty products compan...

Decision Diagnostics Corp. and Its Subsidiary PharmaTech Solutions, Inc. Sue Johnson & Johnson Division LifeScan, Inc. and LifeScan Scotland Ltd. for Antitrust Violations

LOS ANGELES, CA -- (Marketwired) -- 04/04/13 -- Decision Diagnostics Corp. (OTCBB: DECN) the exclusive world-wide sales, service and regulatory processes agent for the Shasta GenStrip, the revolution...

Photocure to exit Allumera business

Photocure plans to exit its Allumera cosmetic dermatology business in the United States, the company recently announced.

Stem cells: A gated exit from pluripotency

Exit from pluripotency is enabled by the exclusion of TFE3 from the nucleus.

Germany's Biotest first drugmaker to exit Greece

FRANKFURT/ATHENS (Reuters) - German pharmaceutical firm Biotest said it would stop shipments to Greece in July, becoming the first drugmaker to announce it would quit the debt-mired country's market b...

Matching PubMed Articles

Medicare Payment Reform and Provider Entry and Exit in the Post-Acute Care Market.

OBJECTIVE: To understand the impacts of Medicare payment reform on the entry and exit of post-acute providers. DATA SOURCES: Medicare Provider of Services data, Cost Reports, and Census data from 1991...

Response to Cembrowski et al. regarding "Could Susceptibility to Low Hematocrit Interference Have Compromised the Results of the NICE-SUGAR Trial?"

COMPETITION AND QUALITY IN HOME HEALTH CARE MARKETS.

Market-based solutions are often proposed to improve health care quality; yet evidence on the role of competition in quality in non-hospital settings is sparse. We examine the relationship between com...

The varying size of exit wounds from center-fire rifles as a consequence of the temporary cavity.

To study the question whether and how the size and position of the temporary cavity influence the morphology and especially the size of a bullet exit wound, test shots were fired to composite models c...

Hospital competition and inpatient services efficiency in Taiwan: a longitudinal study.

There is no consistent evidence of the relationship between market competition and hospital efficiency. Some studies indicated that more competition led to a faster patient turnover rate, higher hospi...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement